Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Business
Classified Sites

The Canadian Press - ONLINE EDITION

Colorado first state to approve experimental drugs for the terminally ill

FILE - Colorado Gov. John Hickenlooper speaks at a news conference at the Capitol in Denver in this Wednesday, May 22, 2013 file photo. Hickenlooper Saturday afternoon May 17, 2014 will sign Colorado's

Enlarge Image

FILE - Colorado Gov. John Hickenlooper speaks at a news conference at the Capitol in Denver in this Wednesday, May 22, 2013 file photo. Hickenlooper Saturday afternoon May 17, 2014 will sign Colorado's "Right To Try" bill, which was passed unanimously in the state Legislature. The "Right To Try" law allows terminally ill patients to obtain experimental drugs without getting federal approval. The bill doesn't require drug companies to provide any drug outside federal parameters, and there's no indication pharmaceutical companies will do so. (AP Photo/Ed Andrieski, File)

DENVER - Nick Auden didn't live to see the legislation, but the case of the Denver melanoma patient who died while seeking access to an experimental drug helped inspire a first-of-its kind law in Colorado.

The "Right To Try" law allows terminally ill patients to obtain experimental drugs without getting federal approval. It's a proposal being advanced in several states by patient advocates who are frustrated by the yearslong federal approval process for experimental drugs in the pipeline.

"There are experimental drugs out there that can and do save lives, and access needs to be expanded," said Auden's widow, Amy Auden of Lone Tree, Colorado. Nick Auden died in November at age 41 after unsuccessfully lobbying two drug companies to use an experimental treatment outside of clinical trials. Auden had acknowledged there was no guarantee the drug would work.

Gov. John Hickenlooper on Saturday signed Colorado's "Right To Try" bill, which was passed unanimously in the state Legislature.

Similar bills await governors' signatures in Louisiana and Missouri, and Arizona voters will decide in November whether to set up a similar program in that state.

Supporters call it a ray of hope for dying patients trying to navigate the red tape of existing "compassionate use" guidelines for obtaining drugs outside clinical trials. The process requires federal approval.

"When you're terminal and there's a drug out there that might help you, it can seem that the obstacles to get that drug are insurmountable," said state Sen. Irene Aguilar, a physician who co-sponsored Colorado's bill.

Aguilar dubbed the measure the "Dallas Buyers Club" bill, after the movie about a determined AIDS patient who smuggled treatments from Mexico because they weren't cleared for use in the U.S.

But skeptics call "Right To Try" a feel-good campaign that won't help dying patients.

The law doesn't require drug companies to provide any drug outside federal parameters, and there's no indication pharmaceutical companies will do so.

A 2003 lawsuit to force the U.S. Food and Drug Administration to expand the availability of investigational drugs failed. A federal judge disagreed that terminally ill people have a right to access to investigational medicine, and the U.S. Supreme Court declined to consider an appeal.

State-level approaches are an effort to circumvent the federal system, but critics say they won't work.

"The FDA regulates drug development, and this doesn't do anything to change that," said Dr. David Gorski, a surgical oncologist and editor of the blog Science Based Medicine.

Gorski said a drug company "wouldn't do anything to endanger a drug they're potentially spending hundreds of millions of dollars to bring to market" through elaborate FDA trials.

Colorado's bill got a careful no-comment from state doctors' groups, hospitals and health insurers. The bill was amended to clarify that health care providers and insurers aren't liable if a patient who uses a drug outside clinical trials gets sick or dies.

Supporters insist the states should push the envelope on clinical trials to speed up the work of federal drug regulators.

"It's so basic, the right to fight for your own life," said Darcy Olsen, president of the Phoenix-based Goldwater Institute, a conservative think-tank that promotes "Right To Try" legislation in state legislatures.

___

Kristen Wyatt can be reached at http://www.twitter.com/APkristenwyatt

___

Online:

House Bill 1281: http://goo.gl/U0OWi3

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

Comment
  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.

letters

Make text: Larger | Smaller

Brandon Sun Business Directory
Sudden Surge: Flood of 2014
Opportunity Magazine — The Bakken
Why Not Minot?
Welcome to Winnipeg

Social Media

Canadian Mortgage Rates